Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines

PharmacoEconomics
Joanne J OrrickDonald D Yin

Abstract

The objective of this study was to compare the inpatient resource use and cost of care for patients hospitalised with community-acquired pneumonia (CAP) who were treated with preferred antibacterial therapy according to the 1998 Infectious Diseases Society of America (IDSA) guidelines with those who were not treated with preferred therapy. A multicentre, observational study was conducted in Florida between 1999 and 2000. Hospitalised adult patients (aged > or = 18 years) started on antibacterial therapy for suspected or confirmed CAP were enrolled in the study. Data collected included patient demographic characteristics, pneumonia risk class, resource use (pharmacy, laboratory, radiology, respiratory services, hospital room and board) and economic data. Risk classification according to Fine et al.'s criteria was determined for each patient. Patient's antibacterial therapy was classified as being preferred or non-preferred according to the 1998 IDSA guidelines. Resource utilisation and cost of care were compared between these two groups. Ninety-nine patients were enrolled in the study. The average age was 60.6 years +/- 20.5 years. The percentage of patients in each risk class (according to Fine et al.) were 11.1% in class I, 39...Continue Reading

References

Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Jun 13, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettT M File
Sep 16, 1998·Clinical Therapeutics·M S NiedermanR Popovian
Nov 26, 1999·Archives of Internal Medicine·G L Armstrong, R W Pinner
Jun 13, 2001·American Journal of Respiratory and Critical Care Medicine·M S NiedermanUNKNOWN American Thoracic Society
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN Infectious Diseases Society of America

❮ Previous
Next ❯

Citations

Nov 24, 2007·Journal of Thrombosis and Thrombolysis·Laura Elizabeth HappeMatt William Sarnes
Jun 17, 2011·International Journal of Clinical Practice·J A Bosso, R H Drew
Apr 17, 2013·Respiratory Research·Francesco BlasiUNKNOWN REACH study group
Jan 6, 2009·Critical Care : the Official Journal of the Critical Care Forum·Jordi Rello
Apr 23, 2013·Applied Health Economics and Health Policy·Reiko SatoBrett Pinsky
Jun 19, 2014·BMC Infectious Diseases·Simone M C SpoorenbergEwoudt M W van de Garde
Jul 7, 2014·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·F DubosA Martinot
Jul 27, 2012·Scandinavian Journal of Infectious Diseases·Carl SpindlerUNKNOWN Community Acquired Pneumonia Working Group of The Swedish Society of Infectious Diseases
Feb 13, 2013·Infectious Disease Clinics of North America·Jennie Johnstone, Lionel Mandell
Aug 27, 2011·Clinics in Chest Medicine·Miquel FerrerAntoni Torres
Apr 2, 2010·The American Journal of Medicine·Marcos I Restrepo, Christopher R Frei
Apr 24, 2007·Thrombosis Research·Andrew F ShorrNikita Mody-Patel
Mar 16, 2016·BMC Medical Informatics and Decision Making·Michael E EggerGuy N Brock
Aug 22, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Howard FriedmanPrakash Navaratnam
Jul 19, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Qing-tao ZhouHong Zhu
Feb 1, 2010·Journal of Pharmacy Practice·Stephen W Nissen, Keith M Olsen
Jan 1, 2019·Expert Review of Respiratory Medicine·Paula PeyraniGlenn S Tillotson
Nov 9, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Andrew F ShorrEileen Farrelly
Mar 20, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Arun ChangolkarEileen Farrelly
Mar 6, 2010·Postgraduate Medicine·Thomas M File, Thomas J Marrie
Oct 22, 2018·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Stacy A TrentJason S Haukoos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.